Page 110 - Immunization Practices News Today

The Food and Drug Administration has approved the first-ever vaccine for respiratory syncytial virus, better known as RSV.

The vaccine should be available in the fall.

The vaccine should be available in the fall.

The vaccine should be available in the fall.

The vaccine should be available in the fall.

After nearly six decades of research and development, the first respiratory syncytial virus (RSV) vaccine has been approved in the U.S.

A vaccine for adults 60 years and older was approved by the FDA for protection against respiratory syncytial virus, making it the first such vaccine to be approved worldwide.

The vaccine should be available in the fall.

After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way.

The vaccine should be available in the fall.